Key Market Indicators
Singaporean imports of insulin saw a significant rise in 2018. Imports reached $6.96 million, up 11% from the previous year. Since 1994, demand has grown by almost 20% year-on-year. Exports of the medication also increased dramatically in 2018, amounting to $1.26 million – a 247% jump compared to 2017. Over the past 24 years, exports have grown by almost 300%. Singapore was ranked 31st for insulin exports in 2018, with Mexico taking the top spot at $1.26 million. France, Italy and China followed in second, third and fourth places respectively.
